Jaguar Health wins FDA fee waivers for Mytesi, Canalevia for fiscal 2027
Bitget2026/09/22 13:06- FDA granted Jaguar Health PDUFA fee waiver for Mytesi for fiscal 2027, lowering expected regulatory user-fee costs.
- FDA’s Center for Veterinary Medicine also waived the fiscal 2027 fee for Canalevia-CA1, its conditionally approved canine diarrhea drug.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The EU questions why a certain exchange continues to operate after being asked to exit
How Strategy keeps STRC near $100 while MSTR stock swings
WTI Crude Oil Drops Over 1.00% Today, Currently at $88.55 per Barrel
Summary of the Bank of Japan's September meeting opinions: Majority of members advocate for continued rate hikes, some call for acceleration.
The summary of the Bank of Japan's September meeting opinions shows that some policymakers believe it is necessary to accelerate interest rate hikes or bring rates closer to the central bank's "target" as soon as possible, increasing the likelihood of further rate hikes.
Crypto prices
More
